These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 21471202)

  • 1. Bone overgrowth-associated mutations in the LRP4 gene impair sclerostin facilitator function.
    Leupin O; Piters E; Halleux C; Hu S; Kramer I; Morvan F; Bouwmeester T; Schirle M; Bueno-Lozano M; Fuentes FJ; Itin PH; Boudin E; de Freitas F; Jennes K; Brannetti B; Charara N; Ebersbach H; Geisse S; Lu CX; Bauer A; Van Hul W; Kneissel M
    J Biol Chem; 2011 Jun; 286(22):19489-500. PubMed ID: 21471202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Domain-Specific Mutation in a Sclerosteosis Patient Suggests a Role of LRP4 as an Anchor for Sclerostin in Human Bone.
    Fijalkowski I; Geets E; Steenackers E; Van Hoof V; Ramos FJ; Mortier G; Fortuna AM; Van Hul W; Boudin E
    J Bone Miner Res; 2016 Apr; 31(4):874-81. PubMed ID: 26751728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lrp4, a novel receptor for Dickkopf 1 and sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo.
    Choi HY; Dieckmann M; Herz J; Niemeier A
    PLoS One; 2009 Nov; 4(11):e7930. PubMed ID: 19936252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levels.
    Chang MK; Kramer I; Huber T; Kinzel B; Guth-Gundel S; Leupin O; Kneissel M
    Proc Natl Acad Sci U S A; 2014 Dec; 111(48):E5187-95. PubMed ID: 25404300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competitive blocking of LRP4-sclerostin binding interface strongly promotes bone anabolic functions.
    Katchkovsky S; Chatterjee B; Abramovitch-Dahan CV; Papo N; Levaot N
    Cell Mol Life Sci; 2022 Jan; 79(2):113. PubMed ID: 35099616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of sclerostin expression by mechanical loading and bone morphogenetic proteins in osteogenic cells.
    Papanicolaou SE; Phipps RJ; Fyhrie DP; Genetos DC
    Biorheology; 2009; 46(5):389-99. PubMed ID: 19940355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the interaction of sclerostin with the low density lipoprotein receptor-related protein (LRP) family of Wnt co-receptors.
    Holdsworth G; Slocombe P; Doyle C; Sweeney B; Veverka V; Le Riche K; Franklin RJ; Compson J; Brookings D; Turner J; Kennedy J; Garlish R; Shi J; Newnham L; McMillan D; Muzylak M; Carr MD; Henry AJ; Ceska T; Robinson MK
    J Biol Chem; 2012 Aug; 287(32):26464-77. PubMed ID: 22696217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling.
    Li X; Zhang Y; Kang H; Liu W; Liu P; Zhang J; Harris SE; Wu D
    J Biol Chem; 2005 May; 280(20):19883-7. PubMed ID: 15778503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin.
    Robling AG; Niziolek PJ; Baldridge LA; Condon KW; Allen MR; Alam I; Mantila SM; Gluhak-Heinrich J; Bellido TM; Harris SE; Turner CH
    J Biol Chem; 2008 Feb; 283(9):5866-75. PubMed ID: 18089564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lrp4 in osteoblasts suppresses bone formation and promotes osteoclastogenesis and bone resorption.
    Xiong L; Jung JU; Wu H; Xia WF; Pan JX; Shen C; Mei L; Xiong WC
    Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3487-92. PubMed ID: 25733894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lrp4 expression by adipocytes and osteoblasts differentially impacts sclerostin's endocrine effects on body composition and glucose metabolism.
    Kim SP; Da H; Li Z; Kushwaha P; Beil C; Mei L; Xiong WC; Wolfgang MJ; Clemens TL; Riddle RC
    J Biol Chem; 2019 Apr; 294(17):6899-6911. PubMed ID: 30842262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Akt-dependent increase in canonical Wnt signaling and a decrease in sclerostin protein levels are involved in strontium ranelate-induced osteogenic effects in human osteoblasts.
    Rybchyn MS; Slater M; Conigrave AD; Mason RS
    J Biol Chem; 2011 Jul; 286(27):23771-9. PubMed ID: 21566129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lrp4 and Wise interplay controls the formation and patterning of mammary and other skin appendage placodes by modulating Wnt signaling.
    Ahn Y; Sims C; Logue JM; Weatherbee SD; Krumlauf R
    Development; 2013 Feb; 140(3):583-93. PubMed ID: 23293290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2.
    Kogawa M; Wijenayaka AR; Ormsby RT; Thomas GP; Anderson PH; Bonewald LF; Findlay DM; Atkins GJ
    J Bone Miner Res; 2013 Dec; 28(12):2436-48. PubMed ID: 23737439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Additional Lrp4 High Bone Mass Mutation Mitigates the Sost-Knockout Phenotype in Mice by Increasing Bone Remodeling.
    Hendrickx G; Boudin E; Mateiu L; Yorgan TA; Steenackers E; Kneissel M; Kramer I; Mortier G; Schinke T; Van Hul W
    Calcif Tissue Int; 2024 Feb; 114(2):171-181. PubMed ID: 38051321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple modes of Lrp4 function in modulation of Wnt/β-catenin signaling during tooth development.
    Ahn Y; Sims C; Murray MJ; Kuhlmann PK; Fuentes-Antrás J; Weatherbee SD; Krumlauf R
    Development; 2017 Aug; 144(15):2824-2836. PubMed ID: 28694256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sclerostin and the regulation of bone formation: Effects in hip osteoarthritis and femoral neck fracture.
    Power J; Poole KE; van Bezooijen R; Doube M; Caballero-Alías AM; Lowik C; Papapoulos S; Reeve J; Loveridge N
    J Bone Miner Res; 2010 Aug; 25(8):1867-76. PubMed ID: 20200987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LRP4 association to bone properties and fracture and interaction with genes in the Wnt- and BMP signaling pathways.
    Kumar J; Swanberg M; McGuigan F; Callreus M; Gerdhem P; Akesson K
    Bone; 2011 Sep; 49(3):343-8. PubMed ID: 21645651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sclerostin: current knowledge and future perspectives.
    Moester MJ; Papapoulos SE; Löwik CW; van Bezooijen RL
    Calcif Tissue Int; 2010 Aug; 87(2):99-107. PubMed ID: 20473488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pigment epithelium-derived factor (PEDF) reduced expression and synthesis of SOST/sclerostin in bone explant cultures: implication of PEDF-osteocyte gene regulation in vivo.
    Li F; Cain JD; Tombran-Tink J; Niyibizi C
    J Bone Miner Metab; 2019 Sep; 37(5):773-779. PubMed ID: 30607618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.